Nucleome Therapeutics raises oversubscribed £37.5 million Series A financing to decode the dark matter of the human genome and deliver first-in-class precision medicines (CDL-Oxford AI ’20)

Announcements

Creative Destruction Lab Connects Entrepreneurs to Global Network with CDL-Doha

With funding from the Qatar Investment Authority and the Qatar Research, Development, and Innovation Council, CDL-Doha will advance research-driven entrepreneurship and strengthen Qatar’s role in the global innovation economy.

Blog Post

ProteinQure: from CDL to the clinic – AI-designed peptide enters Phase I trials for cancer